Evidence map›Paper›PMID 38611731›Full record

ReviewMolecules (Basel, Switzerland)2024

Cyclocurcumin as Promising Bioactive Natural Compound: An Overview.

Carla Gasbarri, Guido Angelini

Abstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Chemical constituents in the rhizome of Curcuma longa and the pharmacological importance of curcumin hybrids.Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents · 2026
    Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Carla GasbarriDepartment of Pharmacy, University "G. d'Annunzio" of Chieti-Pescara, Via dei Vestini, 66100 Chieti, Italy.ORCID 0000-0002-2236-8733
Guido AngeliniDepartment of Pharmacy, University "G. d'Annunzio" of Chieti-Pescara, Via dei Vestini, 66100 Chieti, Italy.ORCID 0000-0001-8353-4590

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although identical in molecular formula and weight, curcumin and cyclocurcumin show remarkable differences in their reactivity. Both are natural compounds isolated from the rhizome of turmeric, the former is involved in the diketo/keto-enol tautomerism through the bis-α,β-unsaturated diketone unit according to the polarity of the solvent, while the latter could react by

Indexed as

CurcuminPyransAntioxidantsAntiviral AgentsMolecular Docking SimulationAntioxidantsAntiviral AgentsCurcumincyclocurcuminPyransbioavailabilitybiological activitycyclocurcumindocking analysisfluorescencephotoisomerizationplatelet aggregationrheumatoid arthritissolvatochromism

Identifiers

PMID38611731
PMCPMC11013289

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.